StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Elite Pharmaceuticals's pe ratio was 5.0× on Oct 19, 2026, against 44.3× a year earlier. Over the last 5 years it ranged from 4.0× to 53.2×, with a median of 9.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20265.0×−44.0
2025Dec 31, 202549.0×+4.7
2024Oct 31, 202444.3×+30.3
2023Dec 29, 202314.0×+9.3
2022Dec 30, 20224.7×−0.7
2021Dec 31, 20215.3×−13.8
2020Dec 31, 202019.2×−94.4
2017Oct 31, 2017113.5×+29.9
2016Dec 30, 201683.6×+15.8
2015Dec 31, 201567.8×+1.6
2014Jan 31, 201466.1×+39.7
2013Dec 31, 201326.5×+20.4
2012Oct 31, 20126.0×–

More Elite Pharmaceuticals figures

See a number that looks wrong?